Stock Information
Nurix Therapeutics Inc (NRIX)
Ticker Symbol: NRIX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,674.28 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -3.4478
Revenue (TTM): $0.33 M
Dividend Yield: N/A%
ROE: -76.09%
Latest News
-
Mizuho Maintains Outperform on Nurix Therapeutics, Raises Price Target to $34
Mon, Jul 13, 2026 8:21 AM
-
Truist Securities Maintains Buy on Nurix Therapeutics, Raises Price Target to $34
Fri, Jul 10, 2026 11:42 AM
-
RBC Capital Maintains Outperform on Nurix Therapeutics, Raises Price Target to $33
Fri, Jul 10, 2026 9:35 AM
-
Stifel Maintains Buy on Nurix Therapeutics, Raises Price Target to $40
Fri, Jul 10, 2026 9:30 AM
-
BTIG Reiterates Buy on Nurix Therapeutics, Maintains $32 Price Target
Fri, Jul 10, 2026 7:58 AM
-
Needham Reiterates Buy on Nurix Therapeutics, Maintains $34 Price Target
Fri, Jul 10, 2026 7:43 AM
-
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $34
Fri, Jul 10, 2026 6:10 AM
-
Nurix Therapeutics Q2 EPS $(0.81) Misses $(0.74) Estimate, Sales $9.043M Miss $16.170M Estimate
Thu, Jul 9, 2026 4:03 PM
Key Financials
Financial data not available
